Dendrimer and cancer: a patent review (2006 – present)

Bibliography

• Svenson S, Tomalia DA. Dendrimers in biomedical applications—reflections on the field. Adv Drug Deliv Rev 2005;57:2106-29
   PubMed Web of Science ®Google Scholar
• Tomalia DA. Interview: an architectural journey: from trees, dendrons/dendrimers to nanomedicine. Interview by Hannah Stanwix. Nanomedicine (Lond) 2012;7:953-6
   PubMed Web of Science ®Google Scholar
• Cheng Y, Xu T. The effect of dendrimers on the pharmacodynamic and pharmacokinetic behaviors of non-covalently or covalently attached drugs. Eur J Med Chem 2008;43:2291-7
   PubMed Web of Science ®Google Scholar
• Menjoge AR, Kannan RM, Tomalia DA. Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discov Today 2010;15:171-85
   PubMed Web of Science ®Google Scholar
• Cheng Y, Zhao L, Li Y, Xu T. Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives. Chem Soc Rev 2011;40:2673-703
   PubMed Web of Science ®Google Scholar
• Lim J, Simanek EE. Triazinedendrimers as drugdelivery systems: from synthesis to therapy. Adv Drug Deliv Rev 2012;64:826-35
   PubMed Web of Science ®Google Scholar
• Hu J, Su Y, Zhang H, Design of interior-functionalized fully acetylated dendrimers for anticancer drug delivery. Biomaterials 2011;32:9950-9
   PubMed Web of Science ®Google Scholar
• Tekade RK, Kumar PV, Jain NK. Dendrimers in oncology: an expanding horizon. Chem Rev 2009;109:49-87
   PubMed Web of Science ®Google Scholar
• Liu H, Wang H, Yang W, Cheng Y. Disulfide cross-linked low generation dendrimers with high gene transfection efficacy, low cytotoxicity, and low cost. J Am Chem Soc 2012;134:17680-7
   PubMed Web of Science ®Google Scholar
• Kesharwan P, Gajbhiye V, Jain NK. A review of nanocarriers for the delivery of small interfering RNA. Biomaterials 2012;33:7138-50
   Google Scholar
• Kobayashi H, Choyke PL. Methods for tumor treatment using dendrimer conjugates. US2006/0204443; 2006
   Google Scholar
• Tomalia DA. Dendritic effects: dependency of dendritic nano-periodic property patterns on critical nanoscale design parameters (CNDPs). New J Chem 2012;36:264-81
   Web of Science ®Google Scholar
• Hong S, Eddington D, Myung JH, Launiere C. Methods and devices for capturing circulating tumor cells. US2012/0077246; 2012
   Google Scholar
• Wei F, Liao W. Probe immobilization and signal amplification for polymer-based biosensor. US2010/0330706; 2010
   Google Scholar
• Yin R, Qin D, Pan J. Symmetrically branched polymer conjugates and microarray assays. US2008/0114077; 2008
   Google Scholar
• Yin R, Qin D, Pan J. Polymer conjugate enhanced bioassays. US2008/0200562; 2008
   Google Scholar
• Weng KC. Nanoparticle labeling reagents and methods of use. US2011/0236957; 2011
   Google Scholar
• Palent PD, Barto RR Jr, Borders TL, Stuart JA. Nano-getter device. WO086561; 2009
   Google Scholar
• Palena PD, Barto RR Jr, Borders TL, Stuart JA. Nano-getter device. US8236243; 2012
   Google Scholar
• Tao WA. Materials and methods for isolating phosphopeptides. US2010/0087008; 2010
   Google Scholar
• Myc A, Majoros IJ, Thomas TP, Baker JR Jr. FRET-based apoptosis detector. US2008/0070266; 2008
   Google Scholar
• Brechbiel MW, Xu H. Method of preparing macromolecular contrast agents and uses thereof. US2010/0056776; 2010
   Google Scholar
• Krippner GY, Wu Z, Peter K, Polylysine dendrimer contrast agent. US2010/0278750; 2010
   Google Scholar
• Tomalia DA, Huang B. Encapsulated (chelate or ligand) dendritic polymers. US2008/0112891; 2008
   Google Scholar
• Villaraza AJL, Bumb A, Brechbiel MW. Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics. Chem Rev 2010;110:2921-59
   PubMed Web of Science ®Google Scholar
• Brechbiel MW, Kobayashi H, Choyke PL, Methods for imaging the lymphatic system using dendrimer-based contrast agents. EP1722825; 2006
   Google Scholar
• Stewart M, Susumu K, Farrell D, Mattoussi HM. Metal oxide-chelating ligands. US8222449; 2012
   Google Scholar
• Willard NP, Wegh RT, Pikkemaat JA, Gruell H. Responsive MRI contrast agents. US2008/0193384; 2008
   Google Scholar
• Willard NP, Wegh RT, Pikkemaat JA, Gruell H. MRI contrast agents comprising CEST active paramagentic complex. EP1881852; 2009
   Google Scholar
• Wegh RT, Pikkemaat JA, Willard NP. Method for using CEST contrast agents in MRI. EP1889086; 2010
   Google Scholar
• Wegh RT, Pikkemaat JA, Willard NP. Method for using CEST contrast agents in MRI. US7917188; 2011
   Google Scholar
• Tsourkas A, Cheng Z. Gadolinium-linked nanoclusters. US2012/0219496; 2012
   Google Scholar
• Huang CH, Nwe K, Zaki AA, Biodegradable polydisulfide dendrimer nanoclusters as MRI contrast agents. ACS Nano 2012;6:9416-24
   PubMed Web of Science ®Google Scholar
• Shi X, Baker JR Jr, Wang S. Functionalized dendrimer-encapsulated and dendrimer-stabilized nanoparticles. US2009/0208580; 2009
   Google Scholar
• Ye JY, Norris TB, Baker JR Jr, Balogh LP. Laser-based method and system for enhancing optical breakdown. US7474919; 2009
   Google Scholar
• Uchegbu I, Schatzlein AG, Dufes C. Bioactive polymers. US2008/0267903; 2008
   Google Scholar
• Lee CY. Dendritic nano-antioxidants. US2010/0247439; 2010
   Google Scholar
• Svenson S, Chauhan AS. Peham dendrimers as excipients. US2009/0324742; 2009
   Google Scholar
• Sousa Hervesn A, Fernandez Megia E, Riguera Vega R. PH-sensitive dendritic polymeric micelles. US2012/0003322; 2012
   Google Scholar
• Sousa Herves A, Fernandez Megia E, Riguera Vega R. PH-sensitive dendritic polymeric micelles. EP2322227; 2011
   Google Scholar
• Sousa Hervesn A, Fernandez Megia E, Riguera Vega R. Dendritic pic micelles with bioactive proteins. US20120269895; 2012
   Google Scholar
• Kissel T, Merkel OM, Mintzer M, Simanek E. Triazine dendrimers and methods of making and using the same for nucleic acid transport. US2010/0093094; 2010
   Google Scholar
• Banerjee P, Reichardt W, Weissleder R, Bogdanov A. Hyperbranched dendron and methods of synthesis and use thereof. US7153905; 2006
   Google Scholar
• Tack F, Janssen HM, Meijer EW, Modified poly(propylene-imine) dendrimers and their use as transfection agents for amionic bioactive factors(as amended). US2010/0298403; 2010
   Google Scholar
• Tack F, Janssen HM, Meijer EW, Modified poly(propylene-imine) dendrimers and their use as transfection agents for anionic bioactive factors. WO006700; 2007
   Google Scholar
• Gunaratne PH, Jayarathne LC, Anderson ML. Interior functionalized hyperbranched dendron-conjugated nanoparticles and uses threrof. US2012/0029062; 2012
   Google Scholar
• Esuvaranathan K, Mahendran R, Lawrencia C. Methods and compositions for delivery of pharmaceutical agents. US7320963; 2008
   Google Scholar
• Esuvaranathan K, Mahendran R, Lawrencia C. Methods and compositions for delivery of pharmaceutical agents. US7709457; 2010
   Google Scholar
• Hawley-Nelson P, Lan J, Shih P, Peptide-enhanced transfections. US8058068; 2011
   Google Scholar
• Hawley-Nelson P, Lan J, Shih P, Peptide-enhanced transfections. EP2206787; 2010
   Google Scholar
• Weber M, Dennig J, Erbacher C. Targeted transfection of cells using a biotinylated dendrimer. US7192744; 2007
   Google Scholar
• Weber M, Dennig J, Erbacher C. Targeted transfection of cells using a biotinylated dendrimer. EP1274462; 2008
   Google Scholar
• Luo D, Li Y. Dendrimer-like modular delivery vector. US20120045430; 2012
   Google Scholar
• Luo D, Li Y. Dendrimer-like modular delivery vector. US2010/0136614; 2010
   Google Scholar
• Liskamp RMJ, Rijkers DTS, Pieters RJ, Dendrimers multivalently substituted with active groups. US2008/0312344; 2008
   Google Scholar
• Malik N, Duncan R, Tomalia DA, Esfand R. An antineoplastic- dendritic polymer drug delivery system. EP1439859; 2007
   Google Scholar
• Huang A, Luo B, Wang J, Zhang Y. Liposome formulations of boronic acid compounds. US2009/0092662; 2009
   Google Scholar
• Forrest L, Cohen M, Cai S. Intralymphatic chemotherapy drug carriers. US8088412; 2012
   Google Scholar
• Li FQ, Chu YL, Zhu S, Multifunctional carrier for the delivery of a pharmacological agent or genetic material into a cell. US7314956; 2008
   Google Scholar
• Jacobson KA, Kim Y, Klutz A, Dendrimer conjugates of agonists and antagonists of the GPCR superfamily. US8153781; 2012
   Google Scholar
• Albrecht V, Wiehe A, Roeder B, Neuberger W. Photo-triggered release of active substances from dendrimer-photosensitizer complexes. US8153111; 2012
   Google Scholar
• Baker JR Jr, Cheng XM, Van Der Spek AFL, Dendrimer conjugates. US2010/0160299; 2010
   Google Scholar
• Gingras M, Raimundo JM, Chabre YM, Dendrimer-drug conjugates. US2008/0020043; 2008
   Google Scholar
• De Groot FMH, Beusker PH, Scheeren JW. Prodrugs built as multiple self-elimination-release spacers. US7705045; 2010
   Google Scholar
• Wilbur DS, Pathare PM, Hamlin DK, Wan F. Water soluble multi-biotin-containing compounds. US7141676; 2006
   Google Scholar
• Krippner GY, Williams CC, Kelly BD, Targeted polylysine dendrimer therapeutic agent. US2010/0292148; 2010
   Google Scholar
• Majoros IJ, Thomas TP, Baker JR Jr, Dendrimer based compositions and methods of using the same. WO033766; 2006
   Google Scholar
• Nilsson R, Sandberg B, Wilbur S. Macromolecule conjugate. US2011/0014151; 2011
   Google Scholar
• Baker JR Jr, Thomas TP, Shukla R. Dendrimer based compositions and methods of using the same. WO009203; 2009
   Google Scholar
• Baker JR Jr, Shukla R, Thomas TP. Dendrimer based compositions and methods of using the same. US2009/0088376; 2009
   Google Scholar
• Baker JR Jr, Zhang Y, Thomas TP, Desai AM. Synthesis of dendrimer conjugates. US2012/0177593; 2012
   Google Scholar
• Baker JR Jr, Holl MMB, Desai A, Synthesis and isolation of dendrimer systems. US20120232225; 2012
   Google Scholar
• Majoros IJ, Thomas TP, Baker JR Jr, Dendrimer based compositions and methods of using the same. EP1796537; 2007
   Google Scholar
• Baker JR Jr, Baohua H. Dendrimer compositions and methods of synthesis. US20120259098; 2012
   Google Scholar
• Shi X, Wang S, Baker JR Jr. Dendrimer based compositions and methods of using the same. WO008483; 2008
   Google Scholar
• Shi XY, Wang SH, Baker JR Jr. Dendrimer based compositions and methods of using the same. US2009/0053139; 2009
   Google Scholar
• William B, Shukla R, Baker JR Jr. Dendrimer based compositions and methods of using the same. US2007/0041934; 2007
   Google Scholar
• Baker JR Jr, Zong H, Thomas TP. Multifunctional small molecules. US2012/0259114; 2012
   Google Scholar
• Baker JR Jr, Banaszak Holl MM, Cheng X-m, Dendrimer based modular platforms. US 2010/0158850; 2010
   Google Scholar
• Baker JR Jr, Banaszak Holl MM, Cheng X-M, Dendrimer based modular platforms. WO075423; 2010
   Google Scholar
• Valentine AM, Dorahy D. Therapeutic agents. US2012/0244123; 2012
   Google Scholar
• Agrez MV. Therapeutic peptides. WO103127; 2009
   Google Scholar
• Livant D. Compounds for, and methods of, treating cancer and inhibiting invasion and metastases. US2012/0077755; 2012
   Google Scholar
• Daftarian PM, Serafini P, Lemmon VP, Compositions, kits and methods for in vitro antigen presentation, assessing immunotoxicity of biologics and drugs. US2012/0129199; 2012
   Google Scholar
• Daftarian PM, Serafini P, Lemmon VP, Vaccine compositions and methods of use thereof. WO115046; 2010
   Google Scholar
• Bay S, Cantacuzene D, Leclerc C, Lo-Man R. Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use threreof. US7696326; 2010
   Google Scholar
• Katti KV, Kannan R, Cutler CS. Gum arabic coated 198gold radioactive nanoparticles for cancer therapy. US2012/0134918; 2012
   Google Scholar
• Khan MK, Minc LD, Nigavekar SS, Fabrication of {198Au0} radioactive composite nanodevices and their use for nano-brachytherapy. Nanomedicine 2008;4:57-69
   PubMed Web of Science ®Google Scholar
• Ray A, Ghandehari H. Radiation enhanced macromolecular delivery of therapeutic agents for chemotherapy technology. US2012/0197060; 2012
   Google Scholar
• Babich JW, Joyal JL, Zimmerman C. Psma-targeted dendrimers. WO078534; 2012
   Google Scholar
• Tjarks W, Tiwari R, Byun Y, Carboranyl thymidine analogues for neutron capture therapy. Chem Commun (Camb) 2007;4978-91
   Google Scholar
• Josefsen LB, Boyle RW. Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics. Theranostics 2012;2:916-66
   PubMed Web of Science ®Google Scholar
• Sakamoto K, Kanazawa S. Dendritic polyamidoamine phthalocyanine derivative. US8030342; 2011
   Google Scholar
• Melancon MP, Zhou M, Li C. Cancer theranostics with near-infrared light-activatable multimodal nanoparticles. Acc Chem Res 2011;44:947-56
   PubMed Web of Science ®Google Scholar
• Dykman L, Khlebtsov N. Gold nanoparticles in biomedical applications: recent advances and perspectives. Chem Soc Rev 2012;41:2256-82
   PubMed Web of Science ®Google Scholar
• Kadushin J, Getts RC. DNA dendrimers as thermal ablation devices. US2011/0206611; 2011
   Google Scholar
• Wu P, Fokin VV, Sharpless KB. Method of using click chemistry to functionalize dendrimers. US2009/0306310; 2009
   Google Scholar
• Wu P, Fokin VV, Sharpless KB. Method for making amphiphilic dendrimers. US2009/0182151; 2009
   Google Scholar
• Harth EM, Calkins DJ, Ende AEVD. Multifunctional degradable nanoparticles with control over size and functionalities. US2011/0274620; 2011
   Google Scholar
• Killops KL, Campos LM, Hawker CJ. Robust, efficient, and orthogonal synthesis of dendrimers via thiol-ene "click" chemistry. J Am Chem Soc 2008;130:5062-4
   PubMed Web of Science ®Google Scholar
• Walter MV, Malkoch M. Simplifying the synthesis of dendrimers: accelerated approaches. Chem Soc Rev 2012;41:4593-609
   PubMed Web of Science ®Google Scholar